Cosciens Biopharma Inc (CSCIF)

[chmcnfunds]

NOT ACCURATE, the 90% may still sell, but the numbers are capped and limited. Per the PR:

___________________________________________________________
approved its previously announced amendment (the "Series B Warrant Amendment") to its outstanding Series B Common Share Purchase Warrants (the "Series B Warrants") agreed to with the holders of approximately 90% of the holders of the Series B Warrants intended to reduce the dilutive effect of the exercise of the Series B Warrants by establishing a cap on the number of shares issuable upon alternate net cashless exercise ("Net Cashless Exercise") of the Series B Warrants until the close of business on November 17, 2015 and by limiting the number of shares that the Consenting Holders may sell until the close of business on October 9, 2015.
______________________________________________________________

(I do not have shares)

AEZS